Efficacy of low-dose continuous infusion of α-human atrial natriuretic peptide (hANP) during cardiac surgery - Possibility of postoperative left ventricular remodeling effect

Circulation Journal

Volumn 70, Issue 11, 2006, Pages 1426-1431

  Sezai, Akira ^a,b   Hata, Mitsumasa ^a   Wakui, Shinji ^a,b   Shiono, Motomi ^a   Negishi, Nanao ^a   Kasamaki, Yuji ^a   Saito, Satoshi ^a   Kato, Jitsu ^a   Minami, Kazutomo ^a,b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Atrial natriuretic factor; Cardiopulmonary bypass; Natriuretic peptide

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; RENIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RENIN RELEASE; UREA NITROGEN BLOOD LEVEL;

AGED; ALDOSTERONE; ARRHYTHMIA; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CARDIOPULMONARY BYPASS; CORONARY ARTERIOSCLEROSIS; CREATINE KINASE, MB FORM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE PERIOD; RENIN; REPERFUSION INJURY; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 33750555987     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1426     Document Type: Article

References (21)

1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89-94.
2. Kangawa K, Matsuo H. Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochem Biophys Res Commun 1984; 120: 333-338.
3. Chu A, Morris KG, Kuehl WD, Cusama J, Nevetta F, Cobb FR. Effects of atrial natriuretic peptide on the coronary vasculature in humans. Circulation 1989; 80: 1627-1635.
4. Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects of left ventricular function. Circulation 1987; 76: 115-124.
5. Maack Y, Marion DN, Camargo MJE, Kleinert HD, Laragh JH, Vaughan ED Jr, et al. Effects of synthetic atrial natriuretic factor on kidney function and the renin-aldosterone system in dogs. Am J Med 1984; 77: 1069-1075.
6. Hayashi M, Tsutamoto T, Wada A, Maeda K, Mabuchi N, Tsutui T, et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with a first anterior acute myocardial infarction. J Am Coll Cardiol 2001; 37: 1820-1826.
7. Sezai A, Shiono M, Orime Y, Hata H, Hata M, Negishi N, et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg 2000; 69: 732-738.
8. Horio H, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 2000; 35: 19-24.
9. Nishimura K, Saito Y, Hidaka T, Ishihara T, Nakao K, Imura H, et al. Does atrial appendectomy aggravate secretary function of atrial natriuretic polypeptide? J Thorac Cardiovasc Surg 1991; 101: 502-508.
10. Wollert KC, Drexler H. The kallikrein-kinin system in post-myocardial infarction cardiac remodeling. Am J Cardiol 1997; 80: 158A-161A.
11. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988; 319: 80-86.
12. Blaufarb IS, Sonnenblick EH. The renin-angiotensin system in left ventricular remodeling. Am J Cardiol 1996; 77: 8C-16C.
13. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: Fibrosis and the renin angiotensin aldosterone system. Circulation 1991; 83: 1849-1865.
14. Tsunemoto H, Nishina T, Nomoto T, Kanemitsu H, Kawakami R, Unimonh O, et al. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair. Circulation 2004; 110(Suppl II): II-174-II-179.
15. Kuga H, Ogawa K, Oida A, Taguchi I, Nakatsugawa M, Hoshi T, et al. Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction. Circ J 2003; 67: 443-448.
16. Takata Y, Hirayama Y, Kiyomi S, Ogawa T, Iga K, Ishii T, et al. The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion. Circ Res 1996; 32: 286-293.
17. Takagi G, Kiuchi K, Endo T, Yamamoto T, Sato N, Nejima J, et al. Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. J Cardiovasc Pharmacol 2000; 36: 22-30.
18. Asakura M, Jiyoong K, Minamino T, Shintani Y, Asanuma H, Kitakaze M. Rationale and design of a large-scale trial using atrial natriuretic peptide (ANP) as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-working groups of acute myocardial infarction for the reduction of necrotic damage by ANP (J-WIND-ANP). Circ J 2004; 68: 95-100.
19. Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, et al. Atrial natriuretic factor in normal subjects and heart failure patients. J Clin Invest 1986; 78: 1362-1374.
20. Saito H, Ogihara T, Nakamura M, Hara H, Higaki J, Rakugi H, et al. Hemodynamic renal and hormonal responses to alpha human atrial natriuretic peptide in patients with congestive heart failure. Clin Pharmacol Ther 1987; 42: 142-147.
21. Valsson F, Ricksten SE, Hedner T, Lundin S. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 1996; 22: 230-236.